Phytanic acid alpha-oxidation, new insights into an old problem: A review

Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids

Volumn 1631, Issue 2, 2003, Pages 119-135

  Wanders, Ronald J A ^a   Jansen, Gerbert A ^a   Lloyd, Matthew D ^b  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b University of Bath   (United Kingdom)

Author keywords

Fatty acid; Peroxisome; Phytanic acid

Indexed keywords

2 HYDROXYPHYTANOYL COENZYME A LYASE; ANTIDIABETIC AGENT; CARBON DIOXIDE; CARBOXYL GROUP; CARRIER PROTEIN; CIGLITAZONE; FORMIC ACID; LONG CHAIN FATTY ACID COENZYME A LIGASE; METHYL GROUP; PHYTANIC ACID; PHYTOL COENZYME A 2 HYDROXYLASE; PIOGLITAZONE; ROSIGLITAZONE; STEROL CARRIER PROTEIN 2; TROGLITAZONE; UNCLASSIFIED DRUG;

BIOACCUMULATION; CELLULAR DISTRIBUTION; CHEMICAL STRUCTURE; CHONDRODYSPLASIA PUNCTATA; ENZYME ACTIVITY; ENZYME MECHANISM; ENZYME PURIFICATION; ENZYMOLOGY; FATTY ACID OXIDATION; HUMAN; LIVER CELL; MITOCHONDRION; MOLECULAR CLONING; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OXIDATION; PEROXISOME; PRIORITY JOURNAL; REFSUM DISEASE; REVIEW; STEREOCHEMISTRY; TISSUE HOMOGENATE; ZELLWEGER SYNDROME;

MAMMALIA;

EID: 0037451008     PISSN: 13881981     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1388-1981(03)00003-9     Document Type: Review

References (91)

1. Klenk E., Kahlke W. Ueber das Vorkommen der 3,7,11,15-Tetramethylhexadecansaure (phytansaure) in den Cholesterinestern und anderen Lipidfraktionen der Organe bei einem Krankheitsfall unbekanter Genese (Verdacht auf Heredopathia atactica polyneuritiformis, Refsum's syndrome). Hoppe-Seyler Z. Physiol. Chem. 333:1963;133-139.
2. Wanders R.J.A., Jakobs C., Skjeldal O.H. Refsum disease. Scriver C.R., Beaudet A.L., Sly W.S., Valle D. The Metabolic and Molecular Bases of Inherited Disease. 2001;3303-3321 McGraw-Hill, New York.
3. Mize C.E., Steinberg D., Avigan J., Fales H.M. A pathway for oxidative degradation of phytanic acid in mammals. Biochem. Biophys. Res. Commun. 25:1966;359-365.
4. Mize C.E., Avigan J., Steinberg D., Pittman R.C., Fales H.M., Milne G.W.A. A major pathway for the mammalian oxidative degradation of phytanic acid. Biochim. Biophys. Acta. 176:1969;720-739.
5. Eldjarn L., Stokke O., Try K. Alpha-oxidation of branched chain fatty acids in man and its failure in patients with Refsum's disease showing phytanic acid accumulation. Scand. J. Clin. Lab. Invest. 18:1966;694-695.
6. Stokke O., Try K., Eldjarn L. Alpha-oxidation as an alternative pathway for the degradation of branched-chain fatty acids in man, and its failure in patients with Refsum's disease. Biochim. Biophys. Acta. 144:1967;271-284.
7. Mihalik S.J., Rainville A.M., Watkins P.A. Phytanic acid alpha-oxidation in rat liver peroxisomes. Production of alpha-hydroxyphytanoyl-CoA and formate is enhanced by dioxygenase cofactors. Eur. J. Biochem. 232:1995;545-551.
8. Tsai S.C., Avigan J., Steinberg D. Studies on the alpha oxidation of phytanic acid by rat liver mitochondria. J. Biol. Chem. 244:1969;2682-2692.
9. Muralidharan V.B., Kishimoto Y. Phytanic acid alpha-oxidation in rat liver. Requirement of cytosolic factor. J. Biol. Chem. 259:1984;13021-13026.
10. Poulos A., Sharp P., Whiting M. Infantile Refsum's disease (phytanic acid storage disease): a variant of Zellweger's syndrome? Clin. Genet. 26:1984;579-586.
11. Poulos A., Sharp P., Fellenberg A.J., Danks D.M. Cerebro-hepato-renal (Zellweger) syndrome, adrenoleukodystrophy, and Refsum's disease: plasma changes and skin fibroblast phytanic acid oxidase. Hum. Genet. 70:1985;172-177.
12. Skjeldal O.H., Stokke O. The subcellular localization of phytanic acid oxidase in rat liver. Biochim. Biophys. Acta. 921:1987;38-42.
13. Watkins P.A., Mihalik S.J. Mitochondrial oxidation of phytanic acid in human and monkey liver: implication that Refsum's disease is not a peroxisomal disorder. Biochem. Biophys. Res. Commun. 167:1990;580-586.
14. Wanders R.J.A., van Roermund C.W.T. Studies on phytanic acid alpha-oxidation in rat liver and cultured human skin fibroblasts. Biochim. Biophys. Acta. 1167:1993;345-350.
15. Huang S., Van Veldhoven P.P., Vanhoutte F., Parmentier G., Eyssen H.J., Mannaerts G.P. Alpha-oxidation of 3-methyl-substituted fatty acids in rat liver. Arch. Biochem. Biophys. 296:1992;214-223.
16. Singh I., Pahan K., Dhaunsi G.S., Lazo O., Ozand P. Phytanic acid alpha-oxidation. Differential subcellular localization in rat and human tissues and its inhibition by nycodenz. J. Biol. Chem. 268:1993;9972-9979.
17. Draye J.P., Van Hoof F., de Hoffmann E., Vamecq J. Peroxisomal oxidation of L-2-hydroxyphytanic acid in rat kidney cortex. Eur. J. Biochem. 167:1987;573-578.
18. Wanders R.J.A., van Roermund C.W.T., Schor D.S., ten Brink H.J., Jakobs C. 2-Hydroxyphytanic acid oxidase activity in rat and human liver and its deficiency in the Zellweger syndrome. Biochim. Biophys. Acta. 1227:1994;177-182.
19. Skjeldal O.H., Stokke O. Evidence against alpha-hydroxyphytanic acid as an intermediate in the metabolism of phytanic acid. Scand. J. Clin. Lab. Invest. 48:1988;97-102.
20. ten Brink H.J., Schor D.S., Kok R.M., Stellaard F., Kneer J., Poll-The B.T., Saudubray J.M., Jakobs C. In vivo study of phytanic acid alpha-oxidation in classic Refsum's disease and chondrodysplasia punctata. Pediatr. Res. 32:1992;566-570.
21. Poulos A., Sharp P., Singh H., Johnson D.W., Carey W.F., Easton C. Formic acid is a product of the alpha-oxidation of fatty acids by human skin fibroblasts: deficiency of formic acid production in peroxisome-deficient fibroblasts. Biochem. J. 292:1993;457-461.
22. 2, cofactor requirements, subcellular localization and formation of a 2-hydroxy-3-methylacyl-CoA intermediate. Eur. J. Biochem. 240:1996;674-683.
23. Jansen G.A., Mihalik S.J., Watkins P.A., Moser H.W., Jakobs C., Denis S., Wanders R.J.A. Phytanoyl-CoA hydroxylase is present in human liver, located in peroxisomes, and deficient in Zellweger syndrome: direct, unequivocal evidence for the new, revised pathway of phytanic acid alpha-oxidation in humans. Biochem. Biophys. Res. Commun. 229:1996;205-210.
24. Jansen G.A., Mihalik S.J., Watkins P.A., Jakobs C., Moser H.W., Wanders R.J.A. Characterization of phytanoyl-coenzyme A hydroxylase in human liver and activity measurements in patients with peroxisomal disorders. Clin. Chim. Acta. 271:1998;203-211.
25. Jansen G.A., Wanders R.J.A., Watkins P.A., Mihalik S.J. Phytanoyl-coenzyme A hydroxylase deficiency - the enzyme defect in Refsum's disease. N. Engl. J. Med. 337:1997;133-134.
26. Jansen G.A., Mihalik S.J., Watkins P.A., Moser H.W., Jakobs C., Heijmans H.S.A., Wanders R.J.A. Phytanoyl-CoA hydroxylase is not only deficient in classical Refsum disease but also in rhizomelic chondrodysplasia punctata. J. Inherit. Metab. Dis. 20:1997;444-446.
27. Braverman N., Steel G., Obie C., Moser A.B., Moser H.W., Gould S.J., Valle D. Human PEX7 encodes the peroxisomal PTS2 receptor and is responsible for rhizomelic chondrodysplasia punctata. Nat. Genet. 15:1997;369-376.
28. Motley A.M., Hettema E.H., Hogenhout E.M., Brites P., ten Asbroek A.L., Wijburg F.A., Baas F., Heijmans H.S.A., Tabak H.F., Wanders R.J.A., Distel B. Rhizomelic chondrodysplasia punctata is a peroxisomal protein targeting disease caused by a non-functional PTS2 receptor. Nat. Genet. 15:1997;377-380.
29. Purdue P.E., Zhang J.W., Skoneczny M., Lazarow P.B. Rhizomelic chondrodysplasia punctata is caused by deficiency of human PEX7, a homologue of the yeast PTS2 receptor. Nat. Genet. 15:1997;381-384.
30. Gould S.J., Valle D. Peroxisome biogenesis disorders: genetics and cell biology. Trends Genet. 16:2000;340-345.
31. Jansen G.A., Ofman R., Ferdinandusse S., Ijlst L., Muijsers A.O., Skjeldal O.H., Stokke O., Jakobs C., Besley G.T., Wraith J.E., Wanders R.J.A. Refsum disease is caused by mutations in the phytanoyl-CoA hydroxylase gene. Nat. Genet. 17:1997;190-193.
32. Jansen G.A., Ofman R., Denis S., Ferdinandusse S., Hogenhout E.M., Jakobs C., Wanders R.J.A. Phytanoyl-CoA hydroxylase from rat liver. Protein purification and cDNA cloning with implications for the subcellular localization of phytanic acid alpha-oxidation. J. Lipid Res. 40:1999;2244-2254.
33. Mihalik S.J., Morrell J.C., Kim D., Sacksteder K.A., Watkins P.A., Gould S.J. Identification of PAHX, a Refsum disease gene. Nat. Genet. 17:1997;185-189.
34. Jansen G.A., Hogenhout E.M., Ferdinandusse S., Waterham H.R., Ofman R., Jakobs C., Skjeldal O.H., Wanders R.J.A. Human phytanoyl-CoA hydroxylase: resolution of the gene structure and the molecular basis of Refsum's disease. Hum. Mol. Genet. 9:2000;1195-1200.
35. Swinkels B.W., Gould S.J., Bodnar A.G., Rachubinski R.A., Subramani S. A novel, cleavable peroxisomal targeting signal at the amino- terminus of the rat 3-ketoacyl-CoA thiolase. EMBO J. 10:1991;3255-3262.
36. de Vet E.C., Zomer A.W.M., Lahaut G.J., van den Bosch H. Polymerase chain reaction-based cloning of alkyl- dihydroxyacetonephosphate synthase complementary DNA from guinea pig liver. J. Biol. Chem. 272:1997;798-803.
37. de Vet E.C., van den Broek B.T., van den Bosch H. Nucleotide sequence of human alkyl-dihydroxyacetonephosphate synthase cDNA reveals the presence of a peroxisomal targeting signal 2. Biochim. Biophys. Acta. 1346:1997;25-29.
38. Croes K., Foulon V., Casteels M., Van Veldhoven P.P., Mannaerts G.P. Phytanoyl-CoA hydroxylase: recognition of 3-methyl-branched acyl-CoAs and requirement for GTP or ATP and Mg(2+) in addition to its known hydroxylation cofactors. J. Lipid Res. 41:2000;629-636.
39. Mukherji M., Chien W., Kershaw N.J., Clifton I.J., Schofield C.J., Wierzbicki A.S., Lloyd M.D. Structure-function analysis of phytanoyl-CoA 2-hydroxylase mutations causing Refsum's disease. Hum. Mol. Genet. 10:2001;1971-1982.
40. Mukherji M., Kershaw N.J., Schofield C.J., Wierzbicki A.S., Lloyd M.D. Utilization of sterol carrier protein-2 by phytanoyl-CoA 2-hydroxylase in the peroxisomal alpha oxidation of phytanic acid. Chem. Biol. 9:2002;597-605.
41. Mukherji M., Kershaw N.J., MacKinnon C.H., Clifton I.J., Wierzbicki A.S., Schofield C.J., Lloyd M.D. 'Chemical co-substrate rescue' of phytanoyl-CoA 2-hydroxylase mutants causing Refsum's disease. Chem. Commun. 2001;972-973.
42. Dubus A., Lloyd M.D., Lee H.J., Schofield C.J., Baldwin J.E., Frere J.M. Probing the penicillin sidechain selectivity of recombinant deacetoxycephalosporin C synthase. Cell. Mol. Life Sci. 58:2001;835-843.
43. Tsai S.C., Steinberg D., Avigan J., Fales H.M. Studies on the stereospecificity of mitochondrial oxidation of phytanic acid and of hydroxyphytanic acid. J. Biol. Chem. 248:1973;1091-1097.
44. Croes K., Casteels M., Dieuaide-Noubhani M., Mannaerts G.P., Van Veldhoven P.P. Stereochemistry of a alpha-oxidation of 3-methyl-branched fatty acids in rat liver. J. Lipid Res. 40:1999;601-609.
45. Kershaw N.J., Mukherji M., MacKinnon C.H., Claridge T.D., Odell B., Wierzbicki A.S., Lloyd M.D., Schofield C.J. Studies on phytanoyl-CoA 2-hydroxylase and synthesis of phytanoyl-coenzyme A. Bioorg. Med. Chem. Lett. 11:2001;2545-2548.
46. Seedorf U., Raabe M., Ellinghaus P., Kannenberg F., Fobker M., Engel T., Denis S., Wouters F., Wirtz K.W.A., Wanders R.J.A., Maeda N., Assmann G. Defective peroxisomal catabolism of branched fatty acyl coenzyme A in mice lacking the sterol carrier protein-2/sterol carrier protein-x gene function. Genes Dev. 12:1998;1189-1201.
47. Prescott A.G., Lloyd M.D. The iron(II) and 2-oxoacid-dependent dioxygenases and their role in metabolism. Nat. Prod. Rep. 17:2000;367-383.
48. Hewitson K.S., McNeill L.A., Riordan M.V., Tian Y.M., Bullock A.N., Welford R.W., Elkins J.M., Oldham N.J., Bhattacharya S., Gleadle J.M., Ratcliffe P.J., Pugh C.W., Schofield C.J. Hypoxia-inducible factor (HIF) asparagine hydroxylase is identical to factor inhibiting HIF (FIH) and is related to the cupin structural family. J. Biol. Chem. 277:2002;26351-26355.
49. Epstein A.C., Gleadle J.M., McNeill L.A., Hewitson K.S., O'Rourke J., Mole D.R., Mukherji M., Metzen E., Wilson M.I., Dhanda A., Tian Y.M., Masson N., Hamilton D.L., Jaakkola P., Barstead R., Hodgkin J., Maxwell P.H., Pugh C.W., Schofield C.J., Ratcliffe P.J. C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation. Cell. 107:2001;43-54.
50. Hegg E.L., Que L. Jr. The 2-His-1-carboxylate facial triad - an emerging structural motif in mononuclear non-heme iron(II) enzymes. Eur. J. Biochem. 250:1997;625-629.
51. Valegard K., van Scheltinga A.C., Lloyd M.D., Hara T., Ramaswamy S., Perrakis A., Thompson A., Lee H.J., Baldwin J.E., Schofield C.J., Hajdu J., Andersson I. Structure of a cephalosporin synthase. Nature. 394:1998;805-809.
52. Lloyd M.D., Lee H.J., Harlos K., Zhang Z.H., Baldwin J.E., Schofield C.J., Charnock J.M., Garner C.D., Hara T., Terwisscha van Scheltinga A.C., Valegard K., Viklund J.A., Hajdu J., Andersson I., Danielsson A., Bhikhabhai R. Studies on the active site of deacetoxycephalosporin C synthase. J. Mol. Biol. 287:1999;943-960.
53. Zhang Z., Ren J., Stammers D.K., Baldwin J.E., Harlos K., Schofield C.J. Structural origins of the selectivity of the trifunctional oxygenase clavaminic acid synthase. Nat. Struct. Biol. 7:2000;127-133.
54. Clifton I.J., Hsueh L.C., Baldwin J.E., Harlos K., Schofield C.J. Structure of proline 3-hydroxylase. Evolution of the family of 2-oxoglutarate dependent oxygenases. Eur. J. Biochem. 268:2001;6625-6636.
55. Wilmouth R.C., Turnbull J.J., Welford R.W., Clifton I.J., Prescott A.G., Schofield C.J. Structure and mechanism of anthocyanidin synthase from Arabidopsis thaliana. Structure (Cambridge). 10:2002;93-103.
56. Croes K., Casteels M., Asselberghs S., Herdewijn P., Mannaerts G.P., Van Veldhoven P.P. Formation of a 2-methyl-branched fatty aldehyde during peroxisomal alpha-oxidation. FEBS Lett. 412:1997;643-645.
57. Verhoeven N.M., Schor D.S., ten Brink H.J., Wanders R.J.A., Jakobs C. Resolution of the phytanic acid alpha-oxidation pathway: identification of pristanal as product of the decarboxylation of 2-hydroxyphytanoyl-CoA. Biochem. Biophys. Res. Commun. 237:1997;33-36.
58. Croes K., Van Veldhoven P.P., Mannaerts G.P., Casteels M. Production of formyl-CoA during peroxisomal alpha-oxidation of 3-methyl-branched fatty acids. FEBS Lett. 407:1997;197-200.
59. Verhoeven N.M., Wanders R.J.A., Schor D.S., Jansen G.A., Jakobs C. Phytanic acid alpha-oxidation: decarboxylation of 2-hydroxyphytanoyl-CoA to pristanic acid in human liver. J. Lipid Res. 38:1997;2062-2070.
60. Jansen G.A., Verhoeven N.M., Denis S., Romeijn G.J., Jakobs C., ten Brink H.J., Wanders R.J.A. Phytanic acid alpha-oxidation: identification of 2-hydroxyphytanoyl-CoA lyase in rat liver and its localisation in peroxisomes. Biochim. Biophys. Acta. 1440:1999;176-182.
61. Foulon V., Antonenkov V.D., Croes K., Waelkens E., Mannaerts G.P., Van Veldhoven P.P., Casteels M. Purification, molecular cloning, and expression of 2-hydroxyphytanoyl-CoA lyase, a peroxisomal thiamine pyrophosphate-dependent enzyme that catalyzes the carbon-carbon bond cleavage during alpha-oxidation of 3-methyl-branched fatty acids. Proc. Natl. Acad. Sci. U.S. A. 96:1999;10039-10044.
62. Lametschwandtner G., Brocard C., Fransen M., Van Veldhoven P., Berger J., Hartig A. The difference in recognition of terminal tripeptides as peroxisomal targeting signal 1 between yeast and human is due to different affinities of their receptor Pex5p to the cognate signal and to residues adjacent to it. J. Biol. Chem. 273:1998;33635-33643.
63. Purdue P.E., Lazarow P.B. Targeting of human catalase to peroxisomes is dependent upon a novel COOH-terminal peroxisomal targeting sequence. J. Cell Biol. 134:1996;849-862.
64. Schellenberger A. Sixty years of thiamin diphosphate biochemistry. Biochim. Biophys. Acta. 1385:1998;177-186.
65. Jordan F. Interplay of organic and biological chemistry in understanding coenzyme mechanisms: example of thiamin diphosphate-dependent decarboxylations of 2-oxo acids. FEBS Lett. 457:1999;298-301.
66. Baetz A.L., Allison M.J. Purification and characterization of oxalyl-coenzyme A decarboxylase from Oxalobacter formigenes. J. Bacteriol. 171:1989;2605-2608.
67. Lung H.Y., Baetz A.L., Peck A.B. Molecular cloning, DNA sequence, and gene expression of the oxalyl-coenzyme A decarboxylase gene, oxc, from the bacterium Oxalobacter formigenes. J. Bacteriol. 176:1994;2468-2472.
68. Rizzo W.B., Carney G., Lin Z. The molecular basis of Sjogren-Larsson syndrome: mutation analysis of the fatty aldehyde dehydrogenase gene. Am. J. Hum. Genet. 65:1999;1547-1560.
69. Jansen G.A., van den Brink D.M., Ofman R., Draghici O., Dacremont G., Wanders R.J.A. Identification of pristanal dehydrogenase activity in peroxisomes: conclusive evidence that the complete phytanic acid alpha-oxidation pathway is localized in peroxisomes. Biochem. Biophys. Res. Commun. 283:2001;674-679.
70. Wanders R.J.A., Denis S., van Roermund C.W.T., Jakobs C., ten Brink H.J. Characteristics and subcellular localization of pristanoyl-CoA synthetase in rat liver. Biochim. Biophys. Acta. 1125:1992;274-279.
71. Mannaerts G.P., Van Veldhoven P., Van Broekhoven A., Vandebroek G., Debeer L.J. Evidence that peroxisomal acyl-CoA synthetase is located at the cytoplasmic side of the peroxisomal membrane. Biochem. J. 204:1982;17-23.
72. Steinberg S.J., Wang S.J., Kim D.G., Mihalik S.J., Watkins P.A. Human very-long-chain acyl-CoA synthetase: cloning, topography, and relevance to branched-chain fatty acid metabolism. Biochem. Biophys. Res. Commun. 257:1999;615-621.
73. Pahan K., Cofer J., Baliga P., Singh I. Identification of phytanoyl-CoA ligase as a distinct acyl-CoA ligase in peroxisomes from cultured human skin fibroblasts. FEBS Lett. 322:1993;101-104.
74. Watkins P.A., Howard A.E., Gould S.J., Avigan J., Mihalik S.J. Phytanic acid activation in rat liver peroxisomes is catalyzed by long-chain acyl-CoA synthetase. J. Lipid Res. 37:1996;2288-2295.
75. Verhoeven N.M., Roe D.S., Kok R.M., Wanders R.J.A., Jakobs C., Roe C. Phytanic acid and pristanic acid are oxidized by sequential peroxisomal and mitochondrial reactions in cultured fibroblasts. J. Lipid Res. 39:1998;66-74.
76. Ferdinandusse S., Mulders J., Ijlst L., Denis S., Dacremont G., Waterham H.R., Wanders R.J.A. Molecular cloning and expression of human carnitine octanoyltransferase: evidence for its role in the peroxisomal beta- oxidation of branched-chain fatty acids. Biochem. Biophys. Res. Commun. 263:1999;213-218.
77. Hunt M.C., Solaas K., Kase B.F., Alexson S.E. Characterization of an acyl-CoA thioesterase that functions as a major regulator of peroxisomal lipid metabolism. J. Biol. Chem. 277:2002;1128-1138.
78. Ofman R., el Mrabet L., Dacremont G., Spijer D., Wanders R.J.A. Demonstration of dimethylnonanoyl-CoA thioesterase activity in rat liver peroxisomes followed by purification and molecular cloning of the thioesterase involved. Biochem. Biophys. Res. Commun. 290:2002;629-634.
79. Jones J.M., Morrell J.C., Gould S.J. Identification and characterization of HAOX1, HAOX2, and HAOX3, three human peroxisomal 2-hydroxy acid oxidases. J. Biol. Chem. 275:2000;12590-12597.
80. Kitareewan S., Burka L.T., Tomer K.B., Parker C.E., Deterding L.J., Stevens R.D., Forman B.M., Mais D.E., Heyman R.A., McMorris T., Weinberger C. Phytol metabolites are circulating dietary factors that activate the nuclear receptor RXR. Mol. Biol. Cell. 7:1996;1153-1166.
81. Lemotte P.K., Keidel S., Apfel C.M. Phytanic acid is a retinoid X receptor ligand. Eur. J. Biochem. 236:1996;328-333.
82. Lemberger T., Desvergne B., Wahli W. Peroxisome proliferator-activated receptors: a nuclear receptor signaling pathway in lipid physiology. Annu. Rev. Cell. Dev. Biol. 12:1996;335-363.
83. Ellinghaus P., Wolfrum C., Assmann G., Spener F., Seedorf U. Phytanic acid activates the peroxisome proliferator-activated receptor alpha (PPARalpha) in sterol carrier protein 2-/sterol carrier protein x-deficient mice. J. Biol. Chem. 274:1999;2766-2772.
84. Wolfrum C., Ellinghaus P., Fobker M., Seedorf U., Assmann G., Börchers T., Spener F. Phytanic acid is ligand and transcriptional activator of murine liver fatty acid binding protein. J. Lipid Res. 40:1999;708-714.
85. Zomer A.W.M., van der Burg B., Jansen G.A., Wanders R.J.A., Poll-The B.T., Van Der Saag P.T. Pristanic acid and phytanic acid. Naturally occurring ligands for the nuclear receptor peroxisome proliferator-activated receptor alpha. J. Lipid Res. 41:2000;1801-1807.
86. McCarty M.F. The chlorophyll metabolite phytanic acid is a natural retinoid-potential for treatment and prevention of diabetes. Med. Hypotheses. 56:2001;217-219.
87. Heim M., Johnson J., Boess F., Bendik I., Weber P., Hunziker W., Fluhmann B. Phytanic acid, a natural peroxisome proliferator-activated receptor (PPAR) agonist, regulates glucose metabolism in rat primary hepatocytes. FASEB J. 16:2002;718-720.
88. Schluter A., Barbera M.J., Iglesias R., Giralt M., Villarroya F. Phytanic acid, a novel activator of uncoupling protein-1 gene transcription and brown adipocyte differentiation. Biochem. J. 362:2002;61-69.
89. Schonfeld P., Struy H. Refsum disease diagnostic marker phytanic acid alters the physical state of membrane proteins of liver mitochondria. FEBS Lett. 457:1999;179-183.
90. Adida A., Spener F. Intracellular lipid binding proteins and nuclear receptors involved in branched-chain fatty acid signaling. Prostaglandins Leukot. Essent. Fat. Acids. 67:2002;98.
91. Pahan K., Gulati S., Singh I. Phytanic acid alpha-oxidation in rat liver mitochondria. Biochim. Biophys. Acta. 1201:1994;491-497.